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Abstract 34 
Objective: To investigate the efficacy of a work-based multicomponent intervention to reduce 35 
office workers’ sitting time. Methods: Offices (n=12; 89 workers) were randomised into an 8-36 
week intervention (n=48) incorporating organisational, individual, and environmental elements 37 
or control arm. Sitting time, physical activity and cardiometabolic health were measured at 38 
baseline and after the intervention. Results: Linear mixed modelling revealed no significant 39 
change in workplace sitting time, but changes in workplace prolonged sitting time (-39 40 
min/shift), sit-upright transitions (7.8 per shift) and stepping time (12 min/shift) at follow-up 41 
were observed, in favour of the intervention group (p<0.001). Results for cardiometabolic 42 
health markers were mixed. Conclusions: This short multicomponent workplace intervention 43 
was successful in reducing prolonged sitting and increasing physical activity in the workplace, 44 
although total sitting time was not reduced and the impact on cardiometabolic health was 45 
minimal.  46 
 47 
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Introduction 50 
Sedentary behaviour can be defined as any waking behaviour characterised by an energy 51 
expenditure ≤1.5 metabolic equivalents (METs) while in a sitting, reclining, or lying posture 52 
(1). High levels of sedentary behaviour are associated with poor metabolic health (2) and an 53 
increased risk of cardiovascular disease, Type 2 diabetes, some cancers and all-cause 54 
mortality, often independently of moderate-to-vigorous physical activity (MVPA) (3-5). A higher 55 
number of interruptions to sedentary time is associated with favourable cardiometabolic risk 56 
marker levels in cross-sectional research (6) and in acute experimental trials in participants 57 
who are healthy, overweight and obese, dysglycaemic, or have type 2 diabetes (7-11). 58 
Office workers spend the majority of their working day in a sedentary state and often 59 
accumulate this in prolonged uninterrupted bouts (12). Therefore, this population are an 60 
important target for interventions to encourage reductions in sedentary behaviour. A number 61 
of previous studies have included one single intervention component, such as the installation 62 
of height-adjustable workstations, over a period of 4-13 weeks in an attempt to reduce 63 
workplace sedentary time (13-15). However,  interventions incorporating organisational, 64 
individual, and environmental-level strategies lasting 4-12 have reported reductions in 65 
workplace sedentary time that are more successful than interventions that focus on singular 66 
components as reported in a recent systematic review (16). Nevertheless , many of these 67 
multicomponent intervention studies have been small-scale and non-randomised (16), which 68 
limits the ability to make definitive conclusions of their impact.  69 
There have been a number of powered randomised controlled trials (RCTs) evaluating 70 
multicomponent interventions (17-20). However, a major limitation of most previous studies is 71 
that participants were randomised at an individual level meaning that there may have been 72 
contamination between groups due to control and intervention participants being located 73 
within the same office. Workplace intervention studies should thus utilise cluster 74 
randomisation at the level of the office or worksite to minimise contamination between groups 75 
in addition to providing greater generalisability and providing more precise treatment effect 76 
estimates for the study outcomes (21). Moreover, some employers do not have the resources 77 
to provide height-adjustable workstations, which have been used in previous multicomponent 78 
interventions. The effect of a powered cluster RCT of a multi-component workplace 79 
intervention that does not necessitate an active workstation therefore requires investigation. 80 
In addition to reductions in workplace sitting, some studies have also examined effects 81 
on cardiometabolic risk markers, with mixed findings. Beneficial mean arterial pressure, 82 
diastolic blood pressure, and high-density lipoprotein cholesterol (HDL) responses have been 83 
observed following 8-13 week single component interventions (13, 15, 22), and improvements 84 
in adiposity have been observed in response to 4-12 week multicomponent interventions (17, 85 
20). However, some studies report no beneficial cardiometabolic response to multicomponent 86 
interventions lasting 4-16 weeks (23, 24). This may be because the interventions were focused 87 
predominantly on interrupting sitting with standing. There is evidence that reallocating sitting 88 
with light or moderate-intensity ambulation is more effective in attenuating cardiometabolic 89 
risk than standing (25); thus, multicomponent interventions with a greater focus on ambulation 90 
should be examined. 91 
The primary aim of this cluster RCT was to evaluate the effectiveness of an 8-week 92 
multicomponent workplace intervention incorporating organisational, individual, and 93 
environmental-level strategies that did not include provision of height-adjustable workstations 94 
and with a greater focus on ambulation for reducing workplace sitting time in office workers. 95 
The secondary aims were to evaluate changes in other workplace activity outcomes (e.g. 96 
prolonged sitting and stepping), sitting time and activity outcomes across the waking day, and 97 
health-related outcomes.  98 
Methods 99 
Study design 100 
This was a two-arm cluster RCT. Ethical approval was granted by the University of 101 
Bedfordshire Institute for Sport and Physical Activity Research Ethics Committee (approval 102 
number 2016ISPAR011). The study was conducted, analysed and reported in accordance 103 
with the CONSORT guidelines for cluster RCTs (26). Participants were randomised by cluster 104 
(i.e., office floor) to receive the intervention or act as the control group. 105 
 106 
Study setting 107 
The trial took place with office-based workers at a national property, residential, construction 108 
and services group organisation located in Bedfordshire, UK. The worksite consisted of 109 
approximately 600 staff working across six floors within two buildings. Recruitment occurred 110 
between November 2016 and January 2017. 111 
 112 
Recruitment 113 
Recruitment of organisation 114 
The organisation was recruited following discussions between the research team and the 115 
worksite Health & Wellbeing Specialist who supported the research team logistically with the 116 
recruitment and intervention procedures. 117 
 118 
Recruitment of participants 119 
A summary of the study was emailed to all workers at the site and the research team attended 120 
the worksite to distribute flyers and discuss the study with interested individuals in communal 121 
areas. Workers were required to express their interest in taking part in the study by writing 122 
their contact details on a sign-up sheet or registering their email address via a digital online 123 
portal. Individuals were then telephone screened by the research team to assess eligibility. A 124 
participant information sheet was then provided and written informed consent obtained prior 125 
to baseline assessment and randomisation. Each employee also gained consent from their 126 
line manager to take part in the study. To encourage participation and full engagement with 127 
the data collection procedures, each participant received a £5 gift voucher following provision 128 
of complete data at each time point. 129 
 130 
Eligibility criteria 131 
Inclusion criteria were: aged 18–70 years, English speaking, spending ≥75% of their working 132 
day seated (self-reported), working ≥three days/week at the same desk, able to stand and 133 
walk unassisted, and designated access to a phone, internet and desk within the worksite. 134 
Exclusion criteria were: pregnancy, non-English speaking, non-ambulatory, night-shift 135 
workers, or a planned absence from the worksite for >two weeks during the study period. 136 
 137 
Assignment to study group 138 
Randomisation was at cluster level to minimise interaction between the intervention and 139 
control groups. A cluster was identified as a distinct division within the worksite. Each division 140 
was located in a separate office workspace. Contamination was also reduced by asking 141 
participants not to disclose their treatment allocation outside of their cluster and by informing 142 
control participants that they would receive components of the intervention once the study was 143 
complete (27). Randomisation occurred after all baseline assessments were completed. 144 
Clusters were randomised 1:1 to either the intervention or control group by the research team. 145 
A randomisation plan for 12 clusters in one block was generated using an online tool 146 
(www.randomization.com) and clusters were randomly matched against this plan using a list 147 
randomiser (www.random.org). 148 
 149 
Sample size 150 
Sample size calculations were performed using GPower (28) based on a minimum difference 151 
of interest of 60 min/day in the primary outcome (workplace sitting time), a SD of 60 min/day, 152 
90% power and 5% alpha. With a total of 12 clusters, an anticipated average cluster size of 153 
six and an estimated intracluster correlation coefficient of 0.05 (29), this gave a design effect 154 
of 1.25. Allowing for 20% attrition within each cluster, this resulted in a total of 84 participants 155 
being required for the study. 156 
 157 
Intervention procedures 158 
Theoretical basis 159 
Beat the Seat is a corporate wellness programme provided by Beat the Seat Ltd. 160 
(http://beattheseat.co.uk/). For the purposes of this study, there was no financial cost to the 161 
participating worksite. Beat the Seat is a multicomponent intervention comprising 162 
organisational, environmental and individual elements focusing on reducing sitting in the 163 
workplace. The integration of multiple components is recommended best practice to influence 164 
behaviour change in the workplace (30). The intervention components were guided by an 165 
intervention taxonomy of behaviour change strategies (31) and published intervention 166 
research (described below). 167 
 168 
Organisational elements 169 
Educational presentation and brainstorming session 170 
Following baseline assessments, all intervention participants received an educational 171 
presentation from the project team informed by scientific evidence on the dangers of excessive 172 
sitting and the benefits of interrupting sitting time (32). Participants then took part in a 173 
brainstorming session to identify and agree upon strategies to reduce sitting within their 174 
workplace. A summary of these strategies was subsequently emailed to all intervention 175 
participants by the project team the following work day. 176 
 177 
Step challenge 178 
Immediately following the educational presentation and brainstorming session, each 179 
participant was provided with a pedometer, goal setting guidance (provided during individual 180 
meetings described below), and took part in a step challenge during the intervention period. 181 
These strategies have been used effectively to reduce sedentary time in working adults (33, 182 
34). Each participant entered their daily steps onto a virtual leaderboard and spot prizes 183 
(shopping gift vouchers) were provided to increase motivation (35). 184 
 185 
Individual elements 186 
Health check report and individual meetings 187 
One week after the educational presentation, participants were provided with a personal health 188 
check report during a ~20 min face-to-face meeting with a member of the project team. The 189 
report was generated from Health Options v9.1.31 software (Health Diagnostics Ltd, Chester, 190 
UK), which is designed for use within National Health Service Health Check programmes. The 191 
report provides risk scores and educational information on diabetes, cholesterol, 192 
cardiovascular disease, and weight management. The elements of this component of the 193 
intervention were based on evidence that receiving health assessment feedback can be a 194 
motivator for behaviour change (36, 37).  195 
During the individual meeting, each participant received a goodie bag that contained a 196 
leaflet briefly outlining the intervention procedures, a facts sheet on the dangers of prolonged 197 
sitting, an information card on “what your steps mean” (i.e. the number of daily steps equating 198 
to low active, moderately active, active, and highly active), sticky notes to place around their 199 
workspace with self-selected reminders to encourage less sitting, and a prompt card to remind 200 
participants of sitting reduction strategies. 201 
 202 
Prompts 203 
Participants received instructions to download computer software (Break Timer, Tom Watson, 204 
Spain) and/or a phone app from a list provided (e.g. Rise & Recharge, Baker Heart and 205 
Diabetes Institute, Australia; Break Reminder, TheBigMom, USA) that prompted them to get 206 
up and move at regular intervals. Participants were advised to set the regularity of the alerts 207 
according to their own personal preference. The use of prompt software in a multicomponent 208 
intervention is effective in reducing workplace sitting and prolonged sitting bouts (38). Point of 209 
decision poster prompts were also displayed around the working environment (e.g. office 210 
walls, notice boards, and near lifts) encouraging employees to interrupt their sitting time and 211 
increase their steps. The combination of prompts to reduce sitting and increase physical 212 
activity are more effective than prompts that focus on sitting time alone (39). 213 
 214 
Telephone support 215 
One-to-one telephone support (5-10 min) was provided weekly from a member of the project 216 
team during intervention weeks 2 to 8 and followed a semi-structured script to maintain 217 
intervention fidelity. Individual-level support is an effective physical activity behaviour change 218 
strategy (36, 40) and reductions in sitting time have been observed when telephone support 219 
is used as part of a multicomponent intervention (41). The telephone calls were based on 220 
motivational interviewing and involved discussions around participant progress toward goals, 221 
problem-solving, and adjustment of goals and behaviour change strategies as necessary. 222 
 223 
Environmental elements 224 
Work environment 225 
Participants were asked to make changes to their working environment in line with strategies 226 
identified during the brainstorming session. Examples of these strategies included removal or 227 
relocation of personal bins and printers, and identification of workspaces or meeting areas to 228 
be used specifically for non-computer based work to encourage movement away from the 229 
desk. 230 
 231 
Data collection 232 
Demographic, anthropometric and cardiometabolic health data were collected at baseline (14-233 
28 days before intervention start) and 8 weeks (3-7 days after the intervention ended) in a 234 
designated room at the study worksite. Participants were asked not to take part in any exercise 235 
and to avoid alcohol and caffeine from the day preceding data collection until after their testing 236 
visit. Participants were also asked to travel to work by car on the day of data collection to 237 
minimise their activity levels. Sitting time and physical activity monitoring took place 7-27 days 238 
prior to intervention start and during the last week of the intervention period. 239 
 240 
Primary outcome 241 
The primary outcome was workplace sitting time measured by the activPAL micro monitor 242 
(PAL Technologies, Glasgow, Scotland). Participants were asked to wear the activPAL on 243 
their right thigh for 24 h/day for seven consecutive days at baseline and during the last 244 
intervention week (week 8). This device provides valid and reliable assessment of sitting, 245 
standing, stepping and postural transitions in adults (42-46) and has been used extensively in 246 
sedentary behaviour research (47). Participants were asked to complete a short daily diary to 247 
note the time they woke up and got out of bed, hours they worked that day, time they went to 248 
bed, time they went to sleep, periods of work time spent not at the primary worksite (e.g. 249 
working from home), and any periods during the day when the device was removed. 250 
 251 
An automated algorithm (48) implemented in STATA was used to process the data 252 
(EventsXYZ.csv file) and identify valid days of wear. Data for working hours were extracted by 253 
matching the work times reported in the daily diary to the processed device data. Where 254 
events (i.e., sitting, standing, stepping) crossed the self-reported start and end work times, 255 
≥50% of the event was required to be within the period of interest for inclusion within that 256 
period (47). Workplace data was deemed valid upon the device being worn >80% of self-257 
reported working hours (49) and ≥1 valid work day was provided during the monitoring period 258 
(18).  259 
 260 
Secondary outcomes 261 
Physical activity and other sitting variables 262 
Other variables of interest calculated were: daily sitting time, and time spent in sitting bout 263 
durations of <30 min and >30min (the latter being defined as a prolonged sitting bout based 264 
on experimental evidence (10)), the number of sit-upright transitions, standing time, time spent 265 
stepping, and steps for work hours and daily (total waking hours). A valid day for daily data 266 
was accepted when meeting the following criteria: a) wear time >10 h, b) >500 steps, and c) 267 
not recording >95% data in one activity category (i.e. sitting, standing or stepping). All valid 268 
days were visually compared to diary notes for quality control prior to the creation of 269 
summative variables.  270 
 271 
Demographic, anthropometric, and cardiometabolic measures 272 
Participant age, sex, ethnicity, marital status, education, and smoking status were recorded at 273 
baseline. At baseline and 8 weeks (post-intervention), participants had height measured 274 
(Leicester Height Measure; Seca, Birmingham, UK) and waist circumference measured at the 275 
umbilicus using an adjustable tape measure (HaB International Ltd., Southam, UK). Body 276 
mass and body fat% were measured using the Tanita BC-418 device (Tanita Corporation, 277 
Tokyo, Japan). Blood pressure was measured whilst sitting using the Omron M5-I automated 278 
oscillatory device (Omron Matsusaka Co Ltd, Matsusaka, Japan) after the participant had 279 
rested for 5 min; three readings were taken and the average recorded. Mean arterial pressure 280 
was calculated as: 𝑀𝑀𝑀𝑀𝑀𝑀 ≅ 𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 + 13 (𝑀𝑀𝑆𝑆𝑆𝑆𝐷𝐷 −  𝑀𝑀𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷). Participants also had total cholesterol and 281 
HDL measured at these time points via finger prick using the CardioChek® system (PTS 282 
Diagnostics, Indianapolis, US) in the non-fasted stated (50). 283 
 284 
Statistical analyses 285 
Statistical analyses were completed using SPSS v23.0 (SPSS Inc., Armonk, N.Y., USA). Data 286 
normality assumption was determined using graphical procedures (quantile-quantile plots) 287 
and deemed plausible in all instances. Outcome variables were analysed using linear mixed 288 
models. Fixed factors (‘arm’ and ‘time’) and random factors (‘participant ID’ and ‘cluster ID’) 289 
were fitted to each model and baseline values for each outcome were included as covariates 290 
to explain residual outcome variance. Post hoc analyses were adjusted using the Sidak 291 
correction for multiple comparisons. Normality for outcome residuals from the final models 292 
were checked and deemed plausible in each instance. Subgroup analysis was performed for 293 
individuals who sat >75% and <75% of their working hours (objectively measured) at baseline 294 
to explore any potential subgroup differences. Sensitivity analyses were also conducted on all 295 
workplace sitting and activity data to assess the impact of number of valid days provided by 296 
including only those with ≥4 days of valid wear. All data are presented as mean (95% 297 
confidence interval [CI]). The two-tailed alpha level for significance testing was set as p≤0.05. 298 
Cohens’ d effect sizes were calculated to describe the magnitude of differences between 299 
conditions; 0.2, 0.5 and 0.8 indicated a small, medium or large effect, respectively (51). 300 
  301 
Results 302 
Participant progression through the study is presented in Figure 1. All participants were 303 
recruited by January 2017 and ended their participation in the study by April 2017. Twelve 304 
clusters were recruited and randomly allocated 1:1 to the intervention or control arm (six each). 305 
Overall, 89 participants were recruited at baseline, with slightly more participants in the 306 
intervention group (n=48) than the control group (n=41). Of these, 100% of clusters and 87.6% 307 
of participants were seen at follow up. At baseline and follow up, 100% and 76.4% of 308 
participants provided valid daily and workplace activPAL data, respectively, all of which 309 
contained valid primary and secondary sitting and activity outcome data for ≥1 day and were 310 
thus included for analysis. Of the sample who provided activPAL data, none were excluded 311 
based on the inclusion restrictions for daily data and workplace data described above. In total, 312 
74.2% of participants provided valid primary and secondary sitting and activity outcome data 313 
at both time points.  314 
 315 
Table 1 provides descriptive data for participants in each study arm. The sample contained 316 
slightly more women than men, were on average approaching middle age, and more than half 317 
of participants were educated to at least tertiary level. Daily activity data at baseline showed 318 
that the sample recruited were highly sedentary, engaging in 10.5 [95% CI: 10.3, 10.6] h/day 319 
of sitting, which accounted for 67.4 [65.7, 69.0] percent of waking hours.  320 
 321 
Primary outcome 322 
Changes in workplace sitting are shown in Table 2. There was no significant difference 323 
between intervention and control in change in sitting time at work (p=0.164).  324 
 325 
Secondary outcomes 326 
Other workplace sitting and activity outcomes 327 
There were significant differences in the change between groups for time spent in prolonged 328 
sitting bouts (-39.2 [95% CI -62.5 to -16.0, p=0.001] min/shift), number of prolonged sitting 329 
bouts (-0.59 [-0.18 to -1.00, p=0.006] bouts/shift), number of sit-upright transitions (7.8 [3.9 to 330 
11.6, p<0.001] transitions/shift), stepping time (12.0 [7.4 to 16.6, p<0.001] min/shift), and 331 
number of steps (1156 [690 to 1622, p<0.001] steps/shift), all in favour of the intervention 332 
group with large effect sizes.  Although not significant, there was also a medium effect for the 333 
change in standing time in favour of the intervention. 334 
 335 
The subgroup analyses (Supplementary Table 1) showed a significant difference in change in 336 
favour of the intervention group for participants spending >75% of their working hours sitting 337 
in prolonged sitting bouts (-61.4 min/shift; p<0.001), number of prolonged sitting bouts (-0.8 338 
bouts/shift; p=0.004), sit-upright transitions (9.0 transitions/shift; p=0.002) and standing time 339 
(27.0 min/shift; p=0.007). There were no significant differences in the change in total 340 
workplace sitting time between intervention and control groups irrespective of whether 341 
participants spent ≤75% or >75% of their working hours sitting. Increases in stepping time 342 
(11.3 and 11.7 min/shift; p<0.001) and steps per shift (1068 and 1114 steps/shift; p<0.001) 343 
were significantly different in favour of the intervention group for both of the <75% workplace 344 
sitting and >75% workplace sitting subgroups, respectively. 345 
 346 
Daily sitting and activity variables 347 
Daily sitting and activity data are shown in Table 3. Significant differences were found between 348 
groups for change in the number of sit-upright transitions (4 [0.8, 7.2] transitions/day) and total 349 
steps (1100 [552, 1650] steps/day), in favour of the intervention group with large effect sizes. 350 
No other significant differences were observed. 351 
 352 
Cardiometabolic variables 353 
Data for cardiometabolic health outcomes are shown in Table 4. The change in waist 354 
circumference between groups (-1.6 cm) was significant (p=0.015) in favour of the intervention 355 
group (large effect), whereas changes in systolic blood pressure (-4.4 mmHg), mean arterial 356 
pressure (-2.4 mmHg) and fat free mass (-0.4 kg) were significant, in favour of the control 357 
group (p=0.010, p=0.040 and p=0.025, respectively) with medium-large effects. There were 358 
no significant differences between groups in any other cardiometabolic health outcome. 359 
 360 
Sensitivity analyses 361 
Sensitivity analyses (Supplementary Table 2) identified that including only those participants 362 
who provided ≥4 days of valid activPAL wear data did not affect any of the intervention effects 363 
observed for the primary or secondary activity outcome results. 364 
 365 
Discussion 366 
This study demonstrates the efficacy of a short-term multi-component workplace intervention 367 
for reducing prolonged sitting time in an office setting. During working hours, the intervention 368 
significantly reduced time spent in prolonged sitting in comparison to the control group, which 369 
indicates that the intervention participants interrupted their sitting time more often, as 370 
evidenced by the concomitant increase in the number of workplace sit-upright transitions. 371 
More frequent sit-upright transitions may have been promoted by a number of the intervention 372 
elements, such as the educational presentation and prompt software. The intervention did not 373 
result in a significant difference (-15.7 min/shift) in workplace sitting time, although there was 374 
a medium effect size in favour of the intervention group. Previous multicomponent 375 
interventions have reported larger reductions (50-125 min/day) in workplace sitting time (17, 376 
19, 20, 23, 24) and some have seen an accompanied reduction in prolonged sedentary time 377 
(17, 23). However, these interventions involved the provision of height-adjustable workstations 378 
or portable pedal machines, whereas the present study did not. This suggests that active 379 
workstation provision may be required in order to significantly reduce total workplace sitting 380 
time. The provision of a height-adjustable workstation permits continued work at a computer 381 
whilst standing (23, 52, 53) as opposed to encouraging regular ambulation. Yet, interrupting 382 
sitting with short frequent bouts of standing only appears to be beneficial metabolically in those 383 
with impaired metabolic health (10), whereas light and moderate intensity ambulation has 384 
stronger associations with metabolic health across the general population, which is more 385 
reflective of the sample in the present study (25). The reduction in prolonged sitting may be 386 
beneficial to health despite the total time spent sitting remaining similar. Indeed, Healy et al. 387 
(6) observed significant beneficial associations between a higher number of interruptions in 388 
sedentary time and cardiometabolic risk markers, independent of total sedentary time. The 389 
current multicomponent intervention was indeed effective in reducing prolonged sitting in the 390 
workplace but may need to be accompanied by an active workstation to significantly reduce 391 
total workplace sitting time. 392 
 393 
The number of daily (total waking hours) sit-upright transitions and daily steps significantly 394 
increased in the intervention group compared with controls. However, the change between 395 
groups in daily prolonged sitting time, total sitting time and the number of daily prolonged 396 
sitting bouts did not differ at follow-up. Although there were reductions in daily prolonged sitting 397 
time and the daily number of prolonged sitting bouts in the intervention group, a concomitant 398 
improvement in the control group rendered the differences between groups non-significant. 399 
As the intervention group reduced prolonged sitting time and increased the number of sit-400 
upright transitions during work hours compared with the control, it could be inferred that being 401 
part of the study motivated the control group to change their behaviour outside of working 402 
hours, given that they did not receive any intervention to assist them in making changes during 403 
work hours. Despite efforts to minimise contamination between study arms, the control group 404 
were aware of the aims of the study and may have had some knowledge of the nature of the 405 
intervention that could have influenced their daily behaviour. The intervention groups’ change 406 
in daily sitting and activity was very similar to their change in workplace sitting and activity, 407 
which suggests that most of the changes observed were not outside of work hours. Therefore, 408 
although there were beneficial changes in daily sit-upright transitions and total steps, this 409 
intervention resulted in more improvements in sitting time and activity variables during working 410 
hours, suggesting that complementary components targeting behaviour changes outside of 411 
work may also be needed. 412 
 413 
Given that the present intervention focused on reducing sitting time, the increased workplace 414 
stepping time appears to be an additional, albeit related, benefit. Previous interventions 415 
targeting sitting reductions using multicomponent interventions involving a height-adjustable 416 
workstation have decreased sitting time at work, whilst marginally increasing workplace 417 
stepping (i.e. by 7%) (17), or observing no effect on stepping at all (18, 23, 52). The only other 418 
established method by which stepping time has been increased was via the use of treadmill 419 
desks in the workplace (54-56). However, the major challenges of large capital investment, 420 
shared usage and long-term adherence remain prominent issues with regards to the 421 
implementation of these in an office environment (54). Nonetheless, it appears that 422 
multicomponent strategies including the provision of both active workstations and pedometers 423 
may be necessary to maximise changes in workplace behaviour (i.e. sitting and physical 424 
activity) for health promotion. 425 
 426 
The present study incorporated the use of pedometers and a step challenge to encourage an 427 
increase in workplace steps, which is an effective strategy for reducing sedentary behaviour 428 
(32, 33). Despite the relatively low cost of pedometers, self-monitoring is an important 429 
technique for behaviour change (31) and intervention groups with the ability to track their own 430 
behaviour have greater improvements in stepping compared to those with no pedometer 431 
access (57). De Cocker, De Bourdeaudhuij, Brown and Cardon (58) and Compernolle, 432 
Vandelanotte, Cardon, De Bourdeaudhuij and De Cocker (59) reported an 896 and 1056 433 
increase in total daily steps, respectively, in addition to reduced daily sitting time (58), in 434 
response to interventions that focused on increasing physical activity levels. However, in the 435 
present study, the intervention did not reduce total workplace or daily sitting, possibly because 436 
the pedometer used did not enable participants to self-monitor their sitting time (the primary 437 
target behaviour). Indeed, there is a distinct lack of self-monitoring tools that focus on sitting 438 
time rather than physical activity (60), hence why a pedometer was chosen supplemented with 439 
computer software to prompt regular breaks in sitting. Nevertheless, the present intervention 440 
appears to have promise for increasing workplace physical activity (in addition to reductions 441 
in prolonged sitting time) given the increase of 1520 steps per day during working time. This 442 
increase in steps, however, had a limited clinical impact on the health variables in the current 443 
study. Previous research has associated an increase of >2000 steps per day with a 10% 444 
reduced risk of a cardiovascular event (61) and a 6% lower risk of all-cause mortality per 1000 445 
steps per day increase (62). More research is warranted to investigate whether similar 446 
increases in steps can evoke health benefits over longer follow-up periods. 447 
 448 
Despite the relatively short nature of the present intervention, a significant 1.6 cm reduction in 449 
waist circumference was observed in the intervention group relevant to the controls. Previous 450 
research has reported no change in waist circumference after a one-month multicomponent 451 
workplace intervention that reduced total and prolonged sedentary time during working hours 452 
(17). This may have been due to sitting time in the study by Danquah et al. (17) being primarily 453 
replaced with standing, while in the present study sitting time appeared to be primarily 454 
replaced with stepping, which elicits a greater increase in energy expenditure (63). Carr, 455 
Karvinen, Peavler, Smith and Cangelosi (20) observed a significant 1.0 cm reduction in waist 456 
circumference following a three-month multicomponent intervention and Freak-Poli, Wolfe, 457 
Backholer, de Courten and Peeters (34) observed a significant 1.6 cm reduction in waist 458 
circumference following a four-month workplace pedometer intervention; each of these studies 459 
primarily replaced sedentary time with cycling or stepping. This supports the efficacy of 460 
workplace sedentary behaviour interventions for improving adiposity levels when sitting is 461 
replaced with activities that expend more energy than standing. Unexpectedly, the control 462 
group had favourable responses in systolic blood pressure, mean arterial pressure and fat-463 
free mass in the present study compared with the intervention group. This could be due to 464 
various factors including changes in dietary behaviours, stress, or treatment contamination 465 
during the study period. A previous single component (height-adjustable workstations) 8-week 466 
intervention that resulted in an 80 min/day reduction in workplace sitting reported beneficial 467 
diastolic blood pressure and total cholesterol responses (22), while a single component prompt 468 
intervention significantly reduced mean arterial pressure (13). However, several 469 
multicomponent interventions lasting 4-16 weeks that reduced workplace sitting by 59-125 min 470 
have reported no cardiometabolic benefits other than reduced waist circumference (20, 23, 471 
24, 64). The reason for the lack of change in many cardiometabolic markers across these 472 
studies may be that the samples were relatively healthy in terms of their cardiometabolic health 473 
and the benefits of interrupting sitting may be more pronounced in obese/dysmetabolic 474 
populations (65-67). Thus, the dose of physical activity (i.e., intensity and duration) and 475 
reductions in prolonged sitting in these studies may have not been sufficient to evoke 476 
beneficial changes in cardiometabolic health. It is well established that interrupting sitting with 477 
short, frequent walking breaks are acutely beneficial to numerous cardiometabolic risk 478 
markers in heterogeneous populations (65). However, these study designs measure 479 
postprandial responses, which may be more sensitive than the single time-point measures 480 
used in the present study (68). Therefore, it is also possible that the lack of cardiometabolic 481 
changes are due to the type of measures employed or the timing of the measurement (i.e., 482 
chronic rather than acute responses). Further research is thus required to examine the 483 
comparative effects of reductions in total sitting time and prolonged sitting time and explore 484 
whether the duration and intensity of activity used to interrupt sitting is an important factor for 485 
cardiometabolic health changes. Moreover, the efficacy of these interventions for improving 486 
cardiometabolic health in obese and dysmetabolic populations requires investigation.  487 
 488 
Strengths of the present study include the fully powered cluster RCT design. Additionally, there 489 
was a successful change in prolonged sitting time at work without the use of height-adjustable 490 
workstations. This is important as the cost-effectiveness of active workstations for reducing 491 
sitting and improving health is yet to be reported (69). Furthermore, sitting, standing and 492 
stepping were measured objectively with a high compliance rate, which presents a further 493 
strength. However, the use of subjective diaries for quality control of the activPAL data is a 494 
potential limitation as participants’ reported waking and working times may not be accurately 495 
reported. Further limitations include the intervention being conducted across one worksite, 496 
which limits the generalisability of the findings to other workplaces where environmental and 497 
cultural differences may affect the impact of the intervention. Additionally, this study was 498 
unable to assess the effectiveness of each individual intervention component. Although 499 
research comparing different intervention strategies is limited, Parry, Straker, Gilson and 500 
Smith (70) reported that no one single strategy was more effective for reducing workplace 501 
sitting. Further research is warranted to determine the comparative effectiveness of different 502 
workplace sitting reduction strategies. The blood sample collection time for the measurement 503 
of lipids was not standardised at each data collection point. Although non-fasting lipid profiles 504 
predict cardiovascular risk (50), it is possible that the timing of prior food intake may minimally 505 
affect HDL concentrations, which could have influenced the findings in the present study. 506 
Additionally, there was no follow-up period post-intervention to ascertain the sustainability of 507 
the behavioural changes observed and whether any longer-term cardiometabolic benefits 508 
could have been achieved. 509 
 510 
In conclusion, this cluster RCT observed a significant reduction in workplace prolonged sitting 511 
time with a concomitant increase in sit-upright transitions and ambulation in office workers. 512 
These workplace changes in sitting and activity occurred without the use of an active 513 
workstation, which suggests that this multicomponent intervention may be an effective low-514 
cost health promotion strategy. 515 
 516 
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Clinical Significance 713 
This study demonstrates the efficacy of an 8-week multicomponent workplace intervention 714 
for reducing prolonged sitting and increasing physical activity in office workers. The 715 
intervention did not use active workstation equipment and may thus offer a cost-effective 716 




Figure captions 721 
Figure 1 – CONSORT diagram of participant progression through the study 722 
Table 1 Baseline characteristics of the study sample by randomisation group      
Characteristic  Intervention group   Control group   All 
n 48  41  89 
Sex (women) 26 (54%)  25 (61%)  51 (57%) 
Age (years) 43.0 (39.4, 46.7)  43.7 (39.7, 47.7)  43.4 (40.7, 45.9) 
Ethnicity (BME) 16.7%  14.6%  15.7% 
Married 33.3%  29.3%  31.5% 
Education (Tertiary) 50.0%  63.4%  56.2% 
Current smoker 4.2%  9.8%  6.7% 
Previous smoker 31.3%  26.8%  29.2% 
BME; Black and minority ethnic group. Age is presented as mean (95% CI).   
723 
 Table 2 Changes in workplace sitting and activity outcomes at follow up by randomisation group 
 Intervention group  Control group Adjusted difference 
(95% CI)b 
Effect 
Sizeb p value Variable n Mean (95% CI)a   n Mean (95% CI)a 
Sitting time per shift (min) 
Baseline 46 395.0 (381.7, 408.3)   41 394.1 (380.1, 408.1)      
Change at 8 weeks 38 -15.7 (-35.7, 4.3)   30 0.9 (-20.6, 22.5) -15.7 (-38.0, 6.5) 0.42 0.164 
Time in sitting bouts >30 min (min)                
Baseline 46 193.0 (179.1, 206.9)   41 191.5 (176.8, 206.2)      
Change at 8 weeks 38 -41.4 (-62.3, -20.5)   30 -0.7 (-23.3, 21.9) -39.2 (-62.5, -16.0) 0.98 0.001 
Number of sitting bouts >30min         
Baseline 46 3.68 (3.43, 3.93)  41 3.63 (3.37, 3.89)    
Change at 8 weeks 38 -0.69 (-1.06, -0.32)  30 -0.05 (-0.45, 0.35) -0.59 (-1.00, -0.18) 0.87 0.006 
Number of sit-upright transitions 
Baseline 46 33.1 (30.9, 35.4)  41 33.2 (30.8, 35.6)    
Change at 8 weeks 38 5.9 (2.5 ,9.3)  30 -1.9 (-5.7, 1.7) 7.8 (3.9, 11.6) 1.16 <0.001 
Standing time (min)                
Baseline 46 95.4 (85.5, 105.3)   41 96.1 (85.7, 106.6)      
Change at 8 weeks 38 15.7 (0.8, 30.5)   30 0.8 (-15.2, 16.9) 14.1 (-2.5, 30.6) 0.51 0.095 
Stepping time (min)                
Baseline 46 34.2 (31.5, 36.9)   41 35.4 (32.5, 38.3)      
Change at 8 weeks 38 15.8 (11.8, 19.9)   30 2.6 (-1.8, 7.0) 12.0 (7.4, 16.6) 1.64 <0.001 
Steps per work shift                
Baseline 46 3264 (2986, 3540)   41 3396 (3104, 3688)      
Change at 8 weeks 38 1520 (1106, 1934)   30 230 (-218, 678) 1156 (690, 1622) 1.57 <0.001 
 
Bold text indicates a statistically significant intervention effect (p≤0.05). 
aEstimated marginal means adjusted for outcome values at baseline. 
bEstimated from pairwise comparisons of marginal means adjusted for outcome values at baseline.
 Table 3 Changes in daily sitting and activity outcomes at follow up by randomisation group 






value Variable n Mean (95% CI)a   n Mean (95% CI)a 
Sitting time per day (min) 
Baseline 46 627.6 (612.3, 643.0)  41 626.5 (609.8, 643.2)    
Change at 8 weeks 38 -14.7 (-37.3, 8.0)  30 -12.5 (-37.9, 12.9) -1.0 (-26.4, 24.4) 0.05 0.936 
Time in sitting bouts >30 min (min)         
Baseline 46 335.2 (317.8, 352.6)  41 334.1 (315.1, 353.1)    
Change at 8 weeks 38 -35.5 (-61.3, -9.7)  30 -26.3 (-55.2, 2.5) -8.1 (-36.9, 20.8) 0.18 0.582 
Number of sitting bouts >30min         
Baseline 46 5.98 (5.69, 6.27)  41 5.91 (5.60, 6.23)    
Change at 8 weeks 38 -0.59 (-1.02, -0.17)  30 -0.36 (-0.83, 0.12) -0.16 (-0.64, 0.31) 0.27 0.498 
Number of sit-upright transitions         
Baseline 46 53.5 (51.6, 55.5)  41 53.8 (51.7, 55.9)    
Change at 8 weeks 38 5.2 (2.4, 8.1)  30 1.0 (-2.2, 4.2) 4.0 (0.8, 7.2) 0.73 0.013 
Standing time (min)         
Baseline 46 220.0 (209.8, 230.2)  41 219.7 (208.5, 230.9)    
Change at 8 weeks 38 2.4 (-12.8, 17.5)  30 15.1 (-1.8, 32.1) -12.5 (-29.5, 4.5) 0.42 0.149 
Stepping time (min)         
Baseline 46 89.0 (84.9, 93.2)  41 90.0 (85.5, 94.5)    
Change at 8 weeks 38 11.8 (5.7, 17.8)  30 9.8 (3.0, 16.6) 1.0 (-5.8, 7.8) 0.16 0.770 
Steps per day         
Baseline 46 7668 (7336, 7998)  41 3863 (7726, 8086)    
Change at 8 weeks 38 1212 (726, 1700)  30 52 (-492, 596) 1100 (552, 1650) 1.19 <0.001 
Bold text indicates a statistically significant intervention effect (p≤0.05). 
aEstimated marginal means adjusted for outcome values at baseline. 
bEstimated from pairwise comparisons of marginal means adjusted for outcome values at baseline. 
 
 
Table 4 Cardiometabolic health changes at follow up by randomisation group 
  Intervention group   Control group Adjusted Difference 
(95% CI)b 
Effect 
Sizeb p-value Variable n Mean (95% CI)a   n Mean (95% CI)a 
Weight (kg) 
 
             
Baseline 48 76.8 (74.7, 79.0)  41 76.0 (73.6, 78.3)    
Change at 8 weeks 43 -2.6 (-5.8, 0.6)  35 -0.1 (-3.6, 3.3) -1.6 (-5.1, 1.9) 0.40 0.373 
Body mass index (kg/m2) 
 
             
Baseline 48 25.9 (25.8, 26.1)  41 25.9 (25.8, 26.1)    
Change at 8 weeks 43 0.1 (-0,2, 0.2)  35 0.0 (-0.2, 0.3) 0.1 (-0.2, 0.3) 0.23 0.675 
Waist circumference (cm) 
 
             
Baseline 48 86.5 (85.7, 87.3)  41 86.4 (85.6, 87.3)    
Change at 8 weeks 43 -2.5 (-3.7, -1.4)  35 -0.9 (-2.2, 0.4) -1.6 (-2.9, -0.3) 0.69 0.015 
Body fat%         
Baseline 48 28.8 (28.4, 29.2)  41 28.8 (28.3, 29.2)    
Change at 8 weeks 43 0.0 (-0.5, 0.6)  35 -0.2 (-0.9, 0.4) 0.3 (-0.3, 0.9) 0.18 0.374 
Fat-free mass (kg)         
Baseline 48 53.4 (53.1, 53.6)  41 53.3 (53.0, 53.6)    
Change at 8 weeks 43 -0.4 (-0.7, 0.0)  35 0.1 (-0.3, 0.5) -0.4 (-0.8, 0.1) 0.70 0.025 
Systolic blood pressure (mmHg)         
Baseline 48 125.4 (123.4, 127.4)  41 126.8 (124.6,129.0)    
Change at 8 weeks 44 -0.4 (-3.3, 2.6)  35 -6.1 (-9.4, 2.8) 4.4 (-7.7, 1.1) 0.65 0.010 
Diastolic blood pressure (mmHg)         
Baseline 48 77.8 (76.5, 79.1)  41 78.8 (77.4, 80.2)    
Change at 8 weeks 44 1.0 (-0.9, 2.9)  35 -1.7 (-3.8, 0.4) 1.7 (-0.5, 3.9) 0.71 0.120 
Mean arterial pressure (mmHg)         
Baseline 48 93.8 (92.4, 95.2)  41 94.8 (93.3, 96.3)    
Change at 8 weeks 44 0.2 (-1.8, 2.2)  35 -3.1 (-5.4, -0.9) 2.4 (0.1, 4.6) 0.82 0.040 
 
HDL, high-density lipoprotein cholesterol. 
Bold text indicates a statistically significant intervention effect (p≤0.05). 
aEstimated marginal means adjusted for outcome values at baseline. 
bEstimated from pairwise comparisons of marginal means adjusted for outcome values at baseline.  
Total cholesterol (mmol/L)         
Baseline 48 4.42 (4.30, 4.55)  41 4.43 (4.29, 4.56)    
Change at 8 weeks 44 0.06 (-0.12, 0.24)  34 -0.01 (-0.21, 0.19) 0.06 (-0.14, 0.26) 0.19 0.538 
HDL (mmol/L)         
Baseline 48 1.39 (1.34, 1.43)  41 1.40 (1.35, 1.45)    
Change at 8 weeks 44 -0.01 (-0.08, 0.05)  34 0.02 (-0.04, 0.09) 0.04 (-0.03, 0.12) -0.24 0.221 
Total cholesterol / HDL ratio         
Baseline 48 3.52 (3.37, 3.66)  41 3.45 (3.29, 3.60)    
Change at 8 weeks 44 -0.02 (-0.24, 0.19)  34 -0.06 (-0.30, 0.18) 0.11 (-0.13, 0.34) 0.09 0.360 
Supplementary Table 1 Changes in workplace sitting and activity outcomes at follow-up by subgroup and randomisation group 
  Intervention group   Control group Adjusted difference 
(95% CI)b p value Variable n Mean (95% CI)a   n Mean (95% CI)a 
Sitting time per day (min) 
Change in <75% workplace sitting 13 -2.7 (-32.5, 27.1)  19 -4.7 (-30.1, 20.7) 2.8 (-25.3, 30.9) 0.842 
Change in >75% workplace sitting 33 -23.3 (-50.5, 3.8)  22 9.4 (-25.4, 44.2) -33.8 (-68.6, 0.9) 0.056 
Time in sitting bouts >30 min (min)        
Change in <75% workplace sitting 13 -12.1 (-51.5, 27.2)  19 2.8 (-30.7, 36.4) -7.8 (-45.2, 29.5) 0.677 
Change in >75% workplace sitting 33 -56.6 (-80.7, -32.5)  22 -0.2 (-31.2, 30.9) -61.4 (-92.3, -30.5) <0.001 
Number of sitting bouts >30min        
Change in <75% workplace sitting 13 -0.1 (-0.9, 0.6)  19 0.2 (-0.4, 0.8) -0.2 (-0.9, 0.5) 0.551 
Change in >75% workplace sitting 33 -1.0 (-1.4, -0.6)  22 -0.3 (-0.8, 0.3) -0.8 (-1.3, -0.3) 0.004 
Number of sit-upright transitions  
Change in <75% workplace sitting 13 0.8 (-4.5, 6.2)  19 -3.6 (-8.2, 0.9) 4.2 (-0.7, 9.2) 0.094 
Change in >75% workplace sitting 33 8.7 (4.2, 13.1)  22 -0.3 (-6.0, 5.5) 9.0 (3.3, 14.7) 0.002 
Standing time (min)        
Change in <75% workplace sitting 13 -17.9 (-47.6, 11.8)  19 -4.4 (-29.7, 20.9) -13.6 (-41.6, 14.4) 0.334 
Change in >75% workplace sitting 33 33.8 (18.7, 48.9)  22 7.5 (-12.1, 27.0) 27.0 (7.7, 46.4) 0.007 
Stepping time (min)        
Change in <75% workplace sitting 13 12.8 (5.2, 20.4)  19 0.1 (-6.4, 6.6) 11.3 (4.0, 18.5) 0.003 
Change in >75% workplace sitting 33 17.2 (12.3, 22.1)  22 5.2 (-1.1, 11.5) 11.7 (5.4, 17.9 <0.001 
Steps per shift        
Change in <75% workplace sitting 13 620 (237, 1004)  19 -10 (-337, 316) 534 (168, 900) 0.005 
Change in >75% workplace sitting 33 821 (572, 1071)  22 251 (-70, 572) 557 (238, 875) 0.001 
Bold text indicates a statistically significant intervention effect (p≤0.05). 
aEstimated marginal means adjusted for outcome values at baseline. 
bEstimated from pairwise comparisons of marginal means adjusted for outcome values at baseline. 
Supplementary Table 2 Sensitivity analysis for workplace sitting and activity outcomes at follow-up 
Variable Intervention group Mean (95% CI) 
Control group 
Mean (95% CI) 
Adjusted difference  
(95% CI)a p-value 
Sitting time per day (min)     
<4 days activity data removed -17.5 (38.1, 3.0) -2.6 (-25.1, 19.8) -14.3 (-37.6, 8.9) 0.225 
Time in sitting bouts >30 min (min)     
<4 days activity data removed -44.0 (-65.2, -22.8) -0.1 (-23.3, 23.0) -41.6 (-65.5, -17.7) 0.001 
Number of sitting bouts >30min     
<4 days activity data removed -0.76 (-1.14, -0.38) 0.02 (-0.39, 0.43) -0.72 (-1.14, -0.29) 0.001 
Number of sit-upright transitions     
<4 days activity data removed 5.9 (2.3, 9.7) -2.9 (-7.0, 1.1) 8.8 (4.6, 13.0) <0.001 
Standing time (min)     
<4 days activity data removed 16.1 (0.3, 32.0) 1.1 (-16.1, 18.4) 14.2 (-3.7, 32.1) 0.120 
Stepping time (min)     
<4 days activity data removed 16.7 (12.7, 20.7) 2.2 (-2.2, 6.6) 13.6 (9.0, 18.3) <0.001 
Steps per shift     
<4 days activity data removed 1612 (1204, 2018) 230 (-216, 674) 1288 (820, 1754) <0.001 
 
Bold text indicates a statistically significant intervention effect (p≤0.05). 
aEstimated from pairwise comparisons of marginal means adjusted for outcome values at baseline. 
 
